Drug Trial Radar · NCT05223166
A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA
Last checked: Nov 19, 2026Latest source record: Jul 20, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Apr 12, 2022
Primary completion
Jul 18, 2023
Study completion Jul 18, 2023
Sponsor
- Lead sponsor
- Citrine Medicine LimitedIndustry
- Sponsor type
- Industry
- First posted
- Feb 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate the efficacy and safety of pitolisant versus placebo during 12 weeks of the Double Blind period, to treat the Excessive Daytime Sleepiness (EDS) in patients with Obstructive Sleep Apnea (OSA) not tolerating or refusing the nasal Continuous Positive Airway Pressure (nCPAP) therapy or treated by nCPAP but still complaining of EDS.
Conditions
- Excessive Daytime Sleepiness
Interventions
PitolisantDrug
Wakix tablet
Placebo oral tabletDrug
Matching placebo tablets will be provided for each strength of active pitolisant film-coated tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline of ESSTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tsinghua Changgung Hospital
Beijing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.